RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
February 22, 2024 06:05 ET
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Granted A New Patent for an Affordable and Effective Device and Method To Detect Ocular And Systemic Diseases
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
December 01, 2023 12:32 ET
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. ANNOUNCES HIRING OF INTERIM CFO
Virender Ahluwalia will serve as Interim Chief Financial Officer
Corza Medical Opens State-of-the-Art Ophthalmology Center of Technology and Innovation, Demonstrating Commitment to Global Eye Care Community
November 30, 2023 08:05 ET
|
Corza Medical Inc.
Corza Medical opens a new Ophthalmology Center of Technology and Innovation in MO to develop next-gen devices for eye treatments and enhance R&D.
SBLA BEAUTY Eye Lift Wand Recognized With “Eye Treatment Product Of The Year ” Award From Beauty Innovation
November 15, 2023 08:00 ET
|
Beauty Innovation Awards
LOS ANGELES, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The 2023 Beauty Innovation Awards today announced that the Eye Lift Wand from SBLA BEAUTY has been selected as “Eye Treatment Product Of The Year” in...
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
November 13, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
November 09, 2023 12:58 ET
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
NATIONAL VISION ALERT: Bragar Eagel & Squire, P.C. is Investigating National Vision Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 12, 2023 02:30 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against National Vision Holdings,...
OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center
July 28, 2023 07:01 ET
|
OKYO Pharma LTD
OKYO plans a 40-patient OK-101 open-label clinical trial with Dr Pedram Hamrah, Tufts Medical Center, as Principal Investigator, a leading expert in treating patients with NCPSecond clinical...
DEADLINE ALERT for SHC, ARBK, and EYE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 27, 2023 12:05 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 27, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...